9 Active TrialsInfusion CenterLarge Center
10 MS centers statewide · Ranked #1 in Arizona for clinical trials · #2 in Arizona for provider count
What kind of place is this?
Comprehensive Care TeamResearch FocusedInfusion On-Site
You’re coming to an academic MS center built around specialized care, coordinated expertise, and a broad range of services in one place. You’ll likely appreciate the on-site infusion suite, multidisciplinary team, and access to imaging, rehabilitation, and second opinions.
Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research5/5
Insurance & Navigation Help4/5
Scheduling & Virtual Care2/5
About Barrow Neurological Institute Multiple Sclerosis Center
It combines MS care, rare neuroimmune disorder expertise, on-site infusion, and research support within one multidisciplinary program.
This Phoenix center cares for people living with MS, including relapsing-remitting, primary-progressive, and secondary-progressive forms, as well as related rare neuroimmune disorders. You can access neurologists, neuroimmunologists, rehabilitation support, diagnostic testing, and on-site infusion care in one place. The team also offers second opinions and a clinical trials program, with care coordinated across multiple specialists. English, Arabic, and Malayalam are spoken here.
Good to know
- Monthly multidisciplinary clinic designed to coordinate care across specialists.
- On-site infusion suite for MS and neuroimmunology treatments.
- Appointments are handled at the 4th floor of the 240 Building.
- Call (855) 806-9718 for MS program appointments and questions.
Barrow Neurological Institute Multiple Sclerosis Center is an academic MS and neuroimmunology program in Phoenix that offers specialty care for MS and related neuroimmune conditions. Patients can receive care through a multidisciplinary team, with infusion services, imaging, rehabilitation, and second opinions all part of the experience.
Featured Care Team Members
Rinu Abraham, MD
Neurologist, Multiple Sclerosis Program; Assistant Professor, Department of Neurology
Neuroimmunology; multiple sclerosis and autoimmune disorders affecting the brain, spinal cord, and peripheral nerves
Huiam Mubarak, MD
Neurologist, Multiple Sclerosis Program; Assistant Professor, Department of Neurology; Director of Barrow Global Neurology
Neuroimmunology; multiple sclerosis and autoimmune disorders affecting the brain and spinal cord
Michael Robers, MD, MS
Neurologist, Multiple Sclerosis Program; Associate Professor, Department of Neurology
Multiple sclerosis and neuroimmunological disorders
Rinu Abraham, MD
Active MS Prescriber
Huiam Mubarak, MD
Michael Robers, M.D.
Active MS Prescriber
Saulena Shafer, D.O.
Active MS Prescriber
Specialized Programs
MS & Neuroimmunology Program
Multidisciplinary clinic
Infusion suite
Clinical trials program
Rare diseases program
Neuro-Rehabilitation Center
Center for Transitional Neuro-Rehabilitation
Barrow Global Neurology
Partnerships & Referral Network
- North American Imaging in MS Cooperative (NAIMS)
Services & Treatments
What They Treat
Multiple sclerosis (MS)Relapsing-remitting MS (RRMS)Primary-progressive MS (PPMS)Secondary-progressive MS (SPMS)Neuromyelitis optica spectrum disorderNeuromyelitis opticaAnti-MOG syndromeAutoimmune encephalitisNeurosarcoidosisSusac syndromeTransverse myelitisAcute disseminated encephalomyelitisOptic neuritisIgG4-related neurological diseaseCentral nervous system vasculitis
How They Treat It
Multiple sclerosis careNeuroimmunology careMultidisciplinary clinicInfusion servicesClinical trials recruitmentRare neuroimmune disorder careNeurology careNeuro-rehabilitationDiagnostic imagingSecond opinionAvonex (interferon beta-1a)Betaseron (interferon beta-1b)Copaxone (glatiramer acetate)Extavia (interferon beta-1b)Glatopa (glatiramer acetate)Kesimpta (ofatumumab)Plegridy (peginterferon beta-1a)Rebif (interferon beta-1a)Aubagio (teriflunomide)Bafiertam (monomethyl fumarate)Gilenya (fingolimod)Mayzent (siponimod)Mavenclad (cladribine)Ponvory (ponesimod)Tascenso ODT (dimethyl fumarate)Tecfidera (dimethyl fumarate)Vumerity (diroximel fumarate)Zeposia (ozanimod)Briumvi (ublituximab-xiiy)Lemtrada (alemtuzumab)Novantrone (mitoxantrone)Ocrevus (ocrelizumab)Tysabri (natalizumab)Tyruko (natalizumab-sztn)Intravenous corticosteroidsPlasma exchangePlasmapheresisIntravenous immunoglobulin (IVIg)Immunosuppressive agentsSteroid treatmentPhysical therapyOccupational therapySpeech and language therapyCognitive rehabilitationNeuropsychological therapyVocational rehabilitation
Diagnostics
MRILumbar punctureEvoked potential testsBlood testsNeurological examMedical history reviewOphthalmology testsAudiogramFluorescein angiographyElectroencephalography (EEG)Diagnostic imagingOphthalmoscopyPupillary light reaction test
Research & Clinical Trials
This center is currently involved in 9 clinical trials — ranked #1 in Arizona for active trials
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
Ocrelizumab
Biobank For MS And Other Demyelinating Diseases
Accelerated Cure Project for Multiple Sclerosis
ACTIVE NOT RECRUITING
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
OfatumumabTetanus toxoid (TT) containing vaccine (Td, Tdap)13-valent pneumococcal conjugate vaccine (13-PCV)23-valent pneumococcal polysaccharide vaccine (23-PPV)Seasonal Quadrivalent influenza vaccineKeyhole limpet hemocyanin (KLH) neo-antigen
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
Ofatumumab approved doseOfatumumab new dose
Study of COYA 302 for the Treatment of ALS
Coya Therapeutics
RECRUITINGPHASE2
COYA 302Placebo
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
ACTIVE NOT RECRUITINGNA
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod
Insurance & Access
Insurance & Support
AetnaAHCCCSBlue Cross Blue ShieldBlue Cross Blue Shield Third PartyCigna Commercial NetworksGovernment PlansHumana Market Place PlansMedicare Advantage PlansUnited Healthcare
Care Coordinator
English, Arabic, Malayalam
Related MS Research
Recent studies relevant to this center's focus areas
FAQs from Barrow Neurological Institute Multiple Sclerosis Center
The center treats multiple sclerosis, including relapsing-remitting, primary-progressive, and secondary-progressive MS. It also cares for related conditions such as neuromyelitis optica spectrum disorder, anti-MOG syndrome, autoimmune encephalitis, optic neuritis, and transverse myelitis.
Yes. The center has an on-site infusion suite and offers treatments such as Ocrevus, Tysabri, Kesimpta, Briumvi, intravenous corticosteroids, IVIg, and plasma exchange when appropriate.
Yes, second opinions are available. This can be helpful if you want a fresh review of your diagnosis, treatment plan, or symptoms.
Yes. The program includes clinical trials recruitment, and the institute has a clinical trials program as part of its MS and neuroimmunology work.
Care is available in English, Arabic, and Malayalam. If language support matters to you, this may make visits easier and more comfortable.
Compare Arizona MS Centers
| Center | Type | Infusion | Virtual | Experience |
|---|---|---|---|---|
Barrow Neurological Institute Multiple Sclerosis Center Phoenix | Academic MS Center | ✓ | — | 3.6/5 |
| Dedicated MS Practice | — | — | 2.8/5 | |
Center for Neurosciences Tucson | Dedicated MS Practice | — | — | 2.6/5 |
| Regional Neurology Group | — | — | 3.8/5 | |
| Academic MS Center | — | — | 3.4/5 | |
| Academic MS Center | — | — | 2.8/5 |
Barrow Neurological Institute Multiple Sclerosis Center
Phoenix • Academic MS Center
Infusion
✓
Virtual
—
Experience
3.6/5
Integrated Multiple Sclerosis Center
Phoenix • Dedicated MS Practice
Infusion
—
Virtual
—
Experience
2.8/5
Center for Neurosciences
Tucson • Dedicated MS Practice
Infusion
—
Virtual
—
Experience
2.6/5
Center for Neurology and Spine
Phoenix • Regional Neurology Group
Infusion
—
Virtual
—
Experience
3.8/5
Mayo Clinic Arizona, Department of Neurology
Scottsdale • Academic MS Center
Infusion
—
Virtual
—
Experience
3.4/5
University of Arizona Neuroimmunology
Tucson • Academic MS Center
Infusion
—
Virtual
—
Experience
2.8/5
MS Centers Across the U.S.
Click a state to browse its MS treatment centers.
Check out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
Information on this page is compiled from public sources including facility websites, ClinicalTrials.gov, CMS data, and AI analysis. It may not be complete or current. Always verify directly with the facility.